Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks

Completed · Not applicable

Conditions studied: Porphyria

In brief

OBJECTIVES: Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.

Key facts

Study ID

NCT00004330

Run by

National Center for Research Resources (NCRR)

Starts

1987-03-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

Where it is running

• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.